Laman UtamaINDGN • NSE
add
Indegene Ltd
Tutup sebelumnya
₹547.75
Julat hari
₹529.00 - ₹556.00
Julat tahun
₹470.10 - ₹736.30
Permodalan pasaran
129.11B INR
Bilangan Purata
278.32K
Nisbah P/E
30.45
Hasil dividen
-
Pertukaran utama
NSE
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (INR) | Mac 2025info | Perubahan T/T |
|---|---|---|
Hasil | 7.56B | 12.28% |
Perbelanjaan pengendalian | 6.29B | 16.30% |
Pendapatan bersih | 1.18B | 24.05% |
Margin untung bersih | 15.56 | 10.43% |
Pendapatan bagi setiap syer | 4.88 | — |
EBITDA | 1.47B | 9.04% |
Kadar cukai berkesan | 21.23% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (INR) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 16.64B | 68.95% |
Jumlah aset | 33.26B | 30.65% |
Jumlah liabiliti | 7.10B | -36.38% |
Jumlah ekuiti | 26.16B | — |
Syer tertunggak | 239.51J | — |
Harga kepada buku | 5.02 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 12.27% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (INR) | Mac 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 1.18B | 24.05% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Indegene Limited is an Indian company that provides research and commercialization services to biopharmaceutical and healthcare enterprises. Based in Bangalore, the company provides consulting in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics. Wikipedia
CEO
Diasaskan
1998
Tapak web
Pekerja
4,367
